Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Free Cash Flow (2022 - 2025)

Bioregenx has reported Free Cash Flow over the past 4 years, most recently at $66579.0 for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 686.03% year-over-year to $66579.0; the TTM value through Dec 2025 reached $29915.0, up 105.83%, while the annual FY2025 figure was $29915.0, 105.83% up from the prior year.
  • Free Cash Flow for Q4 2025 was $66579.0 at Bioregenx, up from -$77564.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $66579.0 in Q4 2025 and troughed at -$649161.0 in Q2 2023.
  • A 4-year average of -$128957.4 and a median of -$32153.0 in 2022 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: tumbled 5528.46% in 2023 and later surged 686.03% in 2025.
  • Year by year, Free Cash Flow stood at -$4364.0 in 2022, then tumbled by 5528.46% to -$245626.0 in 2023, then soared by 95.37% to -$11361.0 in 2024, then surged by 686.03% to $66579.0 in 2025.
  • Business Quant data shows Free Cash Flow for BRGX at $66579.0 in Q4 2025, -$77564.0 in Q3 2025, and $3205.0 in Q2 2025.